A seventh person has essentially been cured of HIV after receiving a stem cell transplant nearly a decade ago, doctors announced Thursday.
The 60-year-old unidentified German man was suffering from acute myeloid leukemia when he underwent the risky procedure to replace his unhealthy bone marrow in October 2015.
He quit taking anti-retroviral drugs which stop HIV from reproducing in September 2018. He remains in viral remission and appears to be cancer-free.
A healthy person has many wishes, a sick person only one, the man, who wishes to remain anonymous, said of his progress.
Dr. Christian Gaebler, a physician-scientist at the Charit-Universittsmedizin Berlin, is slated to present the case next week at the 25thInternational AIDS Conference.
The longer we see these HIV remissions without any HIV therapy, the more confidence we can get that were probably seeing a case where we really have eradicated all competent HIV, Gaebler said.
At a news conference last week, International AIDS Society President Sharon Lewin cautioned against using the word cure.
Still, she said, being in remission for more than five years means he would be close to being considered cured.
There is one major difference between the German mans case and most of the rest.
Five of the other six patients received stem cells from donors with two copies of a rare genetic mutation that stops HIV from replicating.
The German patient is said to be the first to have received stem cells from a donor with just one copy of the mutated gene and he had a copy of the gene himself.
About1% of Caucasians have two copies of thedefective gene, while 10% to 18% of people with European heritage are estimated to have one copy of the gene, thus expanding the potential donor pool.
Some 39 million people around the world are living with HIV, the virus that causes AIDS. Very few will be able to access this treatment, as it is reserved for those with HIV and aggressive leukemia.
Subscribe to our weekly Post Care newsletter!
The rest is here:
7th person likely cured of HIV in a remarkable case - New York Post
